Improving access to innovative cancer drugs
It is essential that we can harness advances in science to bring innovative drugs to people with cancer.
Drug access report - From Patent to Patient
Our 2018 drug access report, From Patent to Patient, highlights the progress that is being made with discovering exciting new cancer medicines. But it also draws attention to key challenges that will need to be overcome to ensure more patients can benefit from these advances.
Download the Drug access report
Cancer drug manifesto
The following year we released a Cancer drug manifesto, calling for action to speed up access to innovative cancer drugs and propose a number of ways we can ensure the most innovative new cancer drugs are available as quickly as possible to all the patients who would benefit from them.
Read the Cancer drug manifesto
Consensus statements on cancer drug pricing and access
And in 2020, we brought the sector together to create a nine point plan looking at practical recommendations to improve access to new cancer treatments. These consensus statements were developed by the ICR with 15 leading academic institutions, charities, stakeholder groups and pharmaceutical companies.
Read the Consensus statements